loading
Precedente Chiudi:
$0.309
Aprire:
$0.2864
Volume 24 ore:
4,188
Relative Volume:
0.00
Capitalizzazione di mercato:
$7.82M
Reddito:
-
Utile/perdita netta:
$-29.80M
Rapporto P/E:
-0.244
EPS:
-1.19
Flusso di cassa netto:
$-25.19M
1 W Prestazione:
-7.87%
1M Prestazione:
-23.52%
6M Prestazione:
-46.89%
1 anno Prestazione:
-64.46%
Intervallo 1D:
Value
$0.2864
$0.31
Intervallo di 1 settimana:
Value
$0.2625
$0.3444
Portata 52W:
Value
$0.25
$0.87

Sensei Biotherapeutics Inc Stock (SNSE) Company Profile

Name
Nome
Sensei Biotherapeutics Inc
Name
Telefono
(240) 243-8000
Name
Indirizzo
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Name
Dipendente
15
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-28
Name
Ultimi documenti SEC
Name
SNSE's Discussions on Twitter

Confronta SNSE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SNSE
Sensei Biotherapeutics Inc
0.31 8.07M 0 -29.80M -25.19M -1.19
Biotechnology icon
ONC
Beigene Ltd Adr
243.16 25.57B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.44 111.79B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.30 39.90M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
591.02 65.28B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
74.00 6.31B 0 -153.72M -103.81M -2.00

Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-14 Iniziato Stephens Overweight
2021-07-01 Downgrade Berenberg Buy → Hold
2021-06-29 Downgrade Oppenheimer Outperform → Perform
2021-03-01 Iniziato Berenberg Buy
2021-03-01 Iniziato Citigroup Buy
2021-03-01 Iniziato Oppenheimer Outperform
2021-03-01 Iniziato Piper Sandler Overweight
Mostra tutto

Sensei Biotherapeutics Inc Borsa (SNSE) Ultime notizie

pulisher
May 26, 2025

VISTA Inhibitor Clinical Trials Market Insights and Drug Development Opportunities Report 2025-2028 Featuring Aurigene, Curis, Hummingbird Bioscience, Kineta, PharmAbcine, Sensei BiotherapeuticsResearchAndMarkets.com - FinancialContent

May 26, 2025
pulisher
May 23, 2025

Sensei Biotherapeutics stockholders approve key proposals By Investing.com - Investing.com Nigeria

May 23, 2025
pulisher
May 23, 2025

Sensei Biotherapeutics stockholders approve key proposals - Investing.com

May 23, 2025
pulisher
May 23, 2025

Sensei Biotherapeutics Approves Reverse Stock Split - TipRanks

May 23, 2025
pulisher
May 08, 2025

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Shares Sold by Renaissance Technologies LLC - Defense World

May 08, 2025
pulisher
May 07, 2025

Sensei Biotherapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2025
pulisher
May 07, 2025

Sensei (SNSE) Reports Encouraging Clinical Results in Recent Qua - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Sensei Biotherapeutics Reports Promising Q1 2025 Results - TipRanks

May 07, 2025
pulisher
May 06, 2025

Sensei Biotherapeutics Reports First Quarter 2025 Financial Resu - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Sensei (SNSE) Reports Encouraging Clinical Results in Recent Quarter | SNSE Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress - The Manila Times

May 06, 2025
pulisher
May 06, 2025

Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress | SNSE Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Sensei Bio's Cancer Drug Achieves Breakthrough: 3X Better Response in PD-L1 Resistant Patients - Stock Titan

May 06, 2025
pulisher
May 05, 2025

Sensei Biotherapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
Apr 11, 2025

SEC Form DEF 14A filed by Sensei Biotherapeutics Inc. - Quantisnow

Apr 11, 2025
pulisher
Apr 03, 2025

Penny Stocks To Add to Your WatchlistMarch 30th - MarketBeat

Apr 03, 2025
pulisher
Apr 02, 2025

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Promising Penny Stocks To ResearchMarch 29th - MarketBeat

Apr 02, 2025
pulisher
Apr 02, 2025

Best Penny Stocks To Follow NowMarch 28th - MarketBeat

Apr 02, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Apr 01, 2025
pulisher
Mar 31, 2025

Sensei Biotherapeutics stock hits 52-week low at $0.34 By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Sensei Biotherapeutics stock hits 52-week low at $0.34 - Investing.com

Mar 31, 2025
pulisher
Mar 30, 2025

HC Wainwright Reiterates Buy Rating for Sensei Biotherapeutics (NASDAQ:SNSE) - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price Expected to Rise, Oppenheimer Analyst Says - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Sensei Biotherapeutics (NASDAQ:SNSE) Price Target Raised to $4.00 at Oppenheimer - Armenian Reporter

Mar 30, 2025
pulisher
Mar 29, 2025

Sensei Biotherapeutics Reports Promising 2024 Results - TipRanks

Mar 29, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics (SNSE) Reports Annual Loss and Decline in Cash Reserves - GuruFocus

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei stock holds Buy rating, $4 target from H.C. Wainwright By Investing.com - Investing.com Australia

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Rockets on FY ’24 Results - Baystreet.ca

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics Reports Favorable Initial Clinical Activity Data For Solnerstotug In Resistant Tumors - Benzinga

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics price target raised to $4 from $3.50 at Oppenheimer - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Oppenheimer Adjusts Price Target on Sensei Biotherapeutics to $4 From $3.50, Maintains Outperform Rating - Marketscreener.com

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics reports FY24 EPS ($1.20) vs ($1.22) last year - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei stock holds Buy rating, $4 target from H.C. Wainwright - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics Inc Cash Runway Into Q2 Of 2026 - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics, Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress - GlobeNewswire

Mar 28, 2025
pulisher
Mar 28, 2025

Breakthrough: Sensei's Cancer Drug Triples Response Rate in Hard-to-Treat Tumors - Stock Titan

Mar 28, 2025
pulisher
Mar 27, 2025

Sensei Biotherapeutics announces initial results from solnerstotug trial portion - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data For Solnerstotug In PD-(L)1 Resistant Tumors - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

Sensei Biotherapeutics : Company Presentation March 2025 - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Revolutionary Cancer Treatment Triples Response Rate in Hard-to-Treat Tumors: Clinical Trial Results Revealed - Stock Titan

Mar 27, 2025
pulisher
Mar 21, 2025

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Sees Large Drop in Short Interest - Defense World

Mar 21, 2025
pulisher
Mar 07, 2025

Sensei Biotherapeutics Stock Price, Quotes and Forecasts | NASDAQ:SNSE - Benzinga

Mar 07, 2025
pulisher
Feb 24, 2025

Sensei Biotherapeutics Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView

Feb 24, 2025
pulisher
Feb 19, 2025

Sensei Biotherapeutics (SNSE) to Release Quarterly Earnings on Wednesday - Defense World

Feb 19, 2025
pulisher
Feb 07, 2025

What Makes Sensei Biotherapeutics (SNSE) a New Buy Stock - MSN

Feb 07, 2025
pulisher
Feb 06, 2025

A stock that deserves closer examination: Sensei Biotherapeutics Inc (SNSE) - US Post News

Feb 06, 2025

Sensei Biotherapeutics Inc Azioni (SNSE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.05
price down icon 8.70%
$30.28
price down icon 2.39%
$576.24
price down icon 0.61%
$285.56
price down icon 1.56%
$4.35
price up icon 1.64%
$73.93
price down icon 2.22%
Capitalizzazione:     |  Volume (24 ore):